GlassScriptPhysician profile
Clem A Ciccarelli
NPI 1881687721
$18,507.17
in general payments reported to CMS, 2019-2025
58 companies · $2,647 in 2025
The $2,647 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,225 · 2020: $2,994 · 2021: $3,192 · 2022: $2,151 · 2023: $2,188 · 2024: $2,110 · 2025: $2,647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,305 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,304.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $640.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,299.07 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $2,215.73 | 2019-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $1,770.62 | 2019-2025 | Vraylar, Linzess, Ubrelvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,467.02 | 2019-2025 | Xifaxan, Trulance |
| Pfizer INC. | $1,271.30 | 2019-2025 | |
| Amgen INC. | $1,090.43 | 2019-2025 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $1,047.09 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Astrazeneca Pharmaceuticals LP | $933.42 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $764.39 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Amarin Pharma, INC. | $668.55 | 2019-2022 | |
| Senseonics, Incorporated | $640.00 | 2025 | Eversense |
| E.R. Squibb & Sons, L.L.C. | $392.20 | 2019-2025 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $355.09 | 2019-2021 | |
| Exact Sciences Corporation | $328.15 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Allergan, INC. | $236.15 | 2019-2020 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clem Ciccarelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.